Amivantamab plus lazertinib is a new standard for EGFR-mutant NSCLC VJOncology 3:50 2 months ago 465 Далее Скачать
Phase III MARIPOSA: amivantamab + lazertinib vs osimertinib in EGFR-mutated NSCLC VJOncology 3:17 1 year ago 1 468 Далее Скачать
Amivantamab and lazertinib in treatment-naïve EGFR-mutant NSCLC VJOncology 2:03 2 years ago 665 Далее Скачать
Amivantamab Plus Lazertinib for EGFR-Mutant Lung Cancer Following Progression on Osimertinib PracticeUpdate 9:02 3 years ago 712 Далее Скачать
New Standard of care Treatment for EGFR Exon 20 Non-small cell Lung Cancer | Dr. Alexander Spira OncBrothers: Practice-Changing Cancer Discussions 0:59 1 year ago 324 Далее Скачать
Amivantamab combo with lazertinib favourable in post-osimertinib EGFR-mutant NSCLC ecancer 9:54 3 years ago 990 Далее Скачать
Amivantamab in combination with lazertinib for osimertinib-relapsed, chemo-naïve EGFRm NSCLC ecancer 16:45 3 years ago 1 373 Далее Скачать
Highlights on amivantamab after progression on osimertinib in EGFR-mutated NSCLC: MARIPOSA-2 European Society for Medical Oncology (ESMO) 4:17 1 year ago 1 627 Далее Скачать
MARIPOSA: longer-term follow-up of amivantamab & lazertinib in EGFR-m NSCLC VJOncology 6:15 2 months ago 135 Далее Скачать
The future of amivantamab and lazertinib in EGFR-mutant NSCLC VJOncology 0:47 1 year ago 228 Далее Скачать
PALOMA-3: subcutaneous vs intravenous amivantamab + lazertinib in refractory EGFR-mutated NSCLC VJOncology 3:27 6 months ago 288 Далее Скачать
MARIPOSA-2: amivantamab + chemo (± lazertinib) vs chemo in EGFR-mutated NSCLC post-osimertinib VJOncology 2:04 1 year ago 781 Далее Скачать
Q&A: What is the Efficacy of Amivantamab and Lazertinib? - Targeted Therapies in Lung Cancer 2023 GRACE - Global Resource for Advancing Cancer Education 5:07 1 year ago 466 Далее Скачать
MARIPOSA Update - Amivantamab + Lazertinib in 1L EGFR mutated metastatic NSCLC. OncBrothers: Practice-Changing Cancer Discussions 0:55 5 months ago 337 Далее Скачать
Expert video report on amivantamab in combination therapy for 1L treatment in EGFRm, advanced NSCLC European Society for Medical Oncology (ESMO) 5:18 1 year ago 2 009 Далее Скачать
Post-progression analysis of MARIPOSA-2: amivantamab + chemo in EGFR+ NSCLC VJOncology 3:21 7 months ago 291 Далее Скачать
MARIPOSA: mechanisms of resistance to 1L amivantamab + lazertinib in pts with EGFR-m NSCLC VJOncology 2:08 3 months ago 165 Далее Скачать
Amivantamab and Lazertinib in EGFR MET+ Disease - 2022 Program: Targeted Therapies Forum - English GRACE - Global Resource for Advancing Cancer Education 1:47 2 years ago 122 Далее Скачать
Managing Amivantamab infusion reaction #2023 #oncology #lungcancer OncBrothers: Practice-Changing Cancer Discussions 0:59 1 year ago 274 Далее Скачать
